Avoro Capital Advisors as of March 31, 2019
Portfolio Holdings for Avoro Capital Advisors
Avoro Capital Advisors holds 32 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 14.7 | $340M | 18M | 19.21 | |
| Mirati Therapeutics | 12.2 | $283M | 3.9M | 73.30 | |
| Ascendis Pharma A S (ASND) | 9.1 | $211M | 1.8M | 117.70 | |
| Amarin Corporation (AMRN) | 7.2 | $166M | 8.0M | 20.76 | |
| Sarepta Therapeutics (SRPT) | 6.2 | $142M | 1.2M | 119.19 | |
| Amicus Therapeutics (FOLD) | 5.6 | $129M | 9.5M | 13.60 | |
| Horizon Pharma | 4.6 | $106M | 4.0M | 26.43 | |
| Zogenix | 4.6 | $105M | 1.9M | 55.01 | |
| Argenx Se (ARGX) | 4.5 | $105M | 840k | 124.84 | |
| Iovance Biotherapeutics (IOVA) | 4.3 | $100M | 11M | 9.51 | |
| BioMarin Pharmaceutical (BMRN) | 4.3 | $100M | 1.1M | 88.83 | |
| Tricida | 2.8 | $66M | 1.7M | 38.62 | |
| Myokardia | 2.2 | $52M | 1.0M | 51.99 | |
| Global Blood Therapeutics In | 2.2 | $50M | 950k | 52.93 | |
| Array BioPharma | 2.1 | $49M | 2.0M | 24.38 | |
| Medicines Company | 1.9 | $44M | 1.6M | 27.95 | |
| BioDelivery Sciences International | 1.7 | $39M | 7.4M | 5.30 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $39M | 310k | 125.26 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $36M | 1.3M | 26.85 | |
| Allogene Therapeutics (ALLO) | 1.3 | $30M | 1.1M | 26.40 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $24M | 2.4M | 10.16 | |
| Intec Pharma | 0.8 | $18M | 2.5M | 7.33 | |
| Assembly Biosciences | 0.8 | $18M | 900k | 19.69 | |
| Pacira Pharmaceuticals (PCRX) | 0.7 | $15M | 400k | 38.06 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $11M | 475k | 24.04 | |
| Cymabay Therapeutics | 0.4 | $9.6M | 725k | 13.28 | |
| Alimera Sciences | 0.3 | $6.6M | 6.2M | 1.06 | |
| Teligent | 0.3 | $6.1M | 5.2M | 1.16 | |
| Fennec Pharmaceuticals (FENC) | 0.2 | $5.4M | 1.1M | 4.85 | |
| Kodiak Sciences (KOD) | 0.2 | $4.1M | 627k | 6.53 | |
| SPDR S&P Biotech (XBI) | 0.1 | $1.3M | 1.0M | 1.27 | |
| Outlook Therapeutics | 0.0 | $630k | 85k | 7.41 |
